The epidermal growth factor receptor is a protein of 1186 amino acyl r
esidues, which appears to be disposed as a 621-residue extracytoplasmi
c domain, a 23-residue transmembrane segment, and a 542-residue cytopl
asmic domain. The binding of EGF to the extracytoplasmic domain of the
receptor causes the dimerization of the receptor and the activation o
f a tyrosyl residue-specific protein kinase that forms part of the cyt
oplasmic domain of the receptor. We have applied a variety of techniqu
es to identify individual residues within the receptor with specific r
eceptor functions. Within the extracytoplasmic domain, residues adjace
nt to bound EGF are being identified by a strategy involving affinity
cross-linking and protein microsequencing. Murine EGF (mEGF), which co
ntains no Lys and therefore has the alpha-amino group as its only prim
ary amine, and site-directed mutants of mEGF, which contain a single L
ys and an Asn1 --> Gln substitution in which the resulting Gln1 is che
mically cyclized to pyroglutamate, are each modified on their single a
mino group with sulfo-N-succinimidyl 4-(fluorosulfonyl) benzoate. The
resulting p-fluorosulfonylbenzoyl derivative of the EGF species is all
owed to bind to the receptor, whereupon it reacts covalently with it.
Limit proteolysis and sequencing are used to identify the modified res
idue of the receptor, e.g., mEGF modified on the alpha-amino terminus
cross-links with Tyr101. Within the cytoplasmic domain, two residues e
ssential for kinase activity have been identified. Lys721, identified
by affinity labeling with 5'-(p-fluorosulfonylbenzoyl) adenosine and p
rotein sequencing, appears to position the alpha- and beta-phosphates
of ATP within the active site and is essential for phosphoryl transfer
. Asp813 appears to function as the catalytic base for phosphoryl tran
sfer, as site-directed mutagenesis of Asp813 --> Ala abolishes kinase
activity. (C) 1995 Academic Press, Inc.